Japan Radiation Oncology Market Size & Outlook, 2020-2028
Japan radiation oncology market, 2017-2028 (US$M)
Related Markets
Japan radiation oncology market highlights
- The Japan radiation oncology market generated a revenue of USD 274.5 million in 2020 and is expected to reach USD 532.9 million by 2028.
- The Japan market is expected to grow at a CAGR of 8.6% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 274.5 million |
| Market revenue in 2028 | USD 532.9 million |
| Growth rate | 8.6% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, Japan accounted for 3.6% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 532.9 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 72.02% in 2020. Horizon Databook has segmented the Japan radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Cancer is the most common cause of death in Japan. Its aging population is one of the major factors responsible for increase in prevalence of cancer. Lung cancer is the leading cause of cancer-related deaths in Japan, followed by stomach and colorectal cancers.
According to WHO, in 2018, Japan had an age-standardized cancer rate of 248.0 per 100,000 people. Moreover, a total of 883,395 new cases of cancer were recorded in Japan. Each year, approximately 13,000 patients undergo radiation therapy in Japan.
The Japanese Foundation for Cancer Research conducts radiation therapy to treat 1,700 patients per year. Geographic expansion of key players to increase their market share and introduction of novel technologies in the country are expected to boost market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan radiation oncology market size, by type, 2017-2028 (US$M)
Japan Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
